NCT01311674Phase 3Terminated

Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)

Study sponsor: Emergent BioSolutions

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2011-03-11Actual
Enrollment · participants141Actual
Source updated2024-03-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.